GRM7 rs3792452: What Your Genotype Means
The rs3792452 variant is a single nucleotide polymorphism located within the GRM7 gene, which encodes a glutamate receptor involved in brain signaling. Research has explored this variant as a potential factor in how individuals respond to methylphenidate, a medication often used for ADHD.
What each genotype means
Common GRM7 genotype
This genotype represents the most frequently observed sequence at this position in many populations. Research into this variant's role in methylphenidate response remains limited and inconclusive, so this result should not be used to guide treatment decisions. Please discuss any questions regarding medication response or dosing with your clinician or pharmacist.
This is the major homozygous genotype and is common across most global populations.
Heterozygous GRM7 genotype
You carry one copy of each allele for this variant. Current scientific literature has not established a definitive clinical impact for this genotype regarding medication response or health outcomes. Because evidence is limited, you should not alter any treatment plans based on this finding and should consult your healthcare provider for personalized medical advice.
This genotype is found at varying frequencies depending on ancestral background, appearing in a significant portion of the population.
Minor homozygous GRM7 genotype
This genotype represents the less common homozygous state for this variant. While some studies have explored the potential influence of GRM7 variants on methylphenidate response, the evidence is currently insufficient to suggest a specific clinical effect for this genotype. Always consult with your doctor or pharmacist before making changes to your medication regimen.
This is the minor homozygous genotype and is generally less common than the CC and CT genotypes across most studied populations.
Understanding the rs3792452 Variant
The rs3792452 variant is a specific change in the DNA sequence within the GRM7 gene. In genetics, a single nucleotide polymorphism (SNP) like this represents a variation at a single position in the genome. This particular variant is located in a region that influences the function or expression of the metabotropic glutamate receptor 7 (mGlu7). Because this receptor is critical for regulating neurotransmission in the central nervous system, researchers often investigate whether variations in the gene sequence might lead to subtle differences in how the brain processes chemical signals. While the variant is cataloged in public databases, it is important to note that its presence is a normal part of human genetic diversity, and it does not inherently indicate a health condition or a specific clinical outcome.
The Role of the GRM7 Gene
The GRM7 gene provides instructions for creating the mGlu7 receptor, a G protein-coupled receptor found on the surface of neurons. This receptor acts as a 'brake' on the release of glutamate, the primary excitatory neurotransmitter in the brain. By modulating the amount of glutamate released at synapses, mGlu7 helps maintain the delicate balance of neural activity required for normal brain function. Because of its role in synaptic transmission, the GRM7 gene is a subject of interest in studies regarding neurodevelopment and psychiatric health. Disruptions or variations in this gene have been studied in the context of various neurodevelopmental disorders, as the receptor is essential for proper axon development and the regulation of signaling pathways that control cognitive and sensory processes.
Research and Evidence Strength
The association between rs3792452 and medication response is considered to have limited evidence. Early research, including a genome-wide association study, identified this SNP as a 'suggestive' finding in relation to how children with ADHD respond to methylphenidate. However, these results did not reach the threshold for genome-wide statistical significance, meaning the findings were preliminary and require replication in larger, more diverse study populations. It is crucial to understand that 'suggestive' associations in genetic research are not definitive clinical predictors. Many factors, including environmental influences, other genetic variants, and individual health history, contribute to how a person responds to a medication. Consequently, this variant cannot be used to predict treatment success or guide clinical decision-making at this time.
What You Can Do With This Information
If you have received information about your rs3792452 genotype, it is important to view it as a piece of scientific data rather than a medical diagnosis. Because the evidence linking this variant to medication response is limited and not clinically validated, it should not be used to make decisions about starting, stopping, or changing any prescribed treatment. Genetic testing for this variant is not currently part of standard clinical practice for ADHD management. If you have questions about your medication, its effectiveness, or potential side effects, the most appropriate step is to discuss these concerns with your clinician or pharmacist. They can provide personalized guidance based on your full medical history, current symptoms, and established clinical guidelines, which are far more reliable than individual genetic markers.
How common is this variant?
The frequency of the rs3792452 alleles is variable across different global populations, with no single genotype being universally dominant.
Frequently asked questions
Can I use my rs3792452 result to choose ADHD medication?
No. The evidence linking this variant to methylphenidate response is limited and preliminary. It is not a validated clinical tool for selecting or dosing medications.
Is rs3792452 a mutation that causes disease?
No. rs3792452 is a common genetic polymorphism, which is a normal variation in the human genome. It is not classified as a disease-causing mutation.
Where can I find more information about GRM7?
You can find reliable information about the GRM7 gene through resources like MedlinePlus Genetics, the Alliance of Genome Resources, or the NCBI Gene database.
Should I change my medication based on my genetic report?
You should never change your medication based on genetic reports without consulting your doctor. Always speak with your healthcare provider before making any changes to your treatment plan.
Sources & further reading
Educational information only, last refreshed 10/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3792452?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29